MetaCap

Who Owns Cardiol Therapeutics Stock?

NASDAQ: CRDLHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.8626-0.0201 (-2.28%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
26.91%
Institutional holders
62
  • Institutions 26.9%
  • Insiders 2.2%
  • Public and other 70.9%

Who owns Cardiol Therapeutics stock?

Institutional investors own about 26.9% of Cardiol Therapeutics's shares, spread across 62 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 2.22% of CRDL.

The largest institutional holders are MMCAP International, Inc. SPC (12.83%), Tejara Capital Ltd (6.10%) and Ikarian Capital, LLC (2.73%). Together, the top 10 institutions control 25.2% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their CRDL positions and 2 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of CRDL

Cardiol Therapeutics top institutional holders
InstitutionShares% HeldChange
MMCAP International, Inc. SPC15.60M12.83%0.0%
Tejara Capital Ltd7.42M6.10%+45.1%
Ikarian Capital, LLC3.33M2.73%+22.0%
Morgan Stanley1.01M0.83%+184.7%
Boothbay Fund Management, LLC975.72K0.80%+22.8%
Citadel Advisors Llc796.53K0.65%-2.9%
Two Sigma Investments, LP746.94K0.61%+39.8%
Goldman Sachs Group Inc333.90K0.27%+0.5%
Integrity Alliance, Llc.310.90K0.26%-20.0%
Jane Street Group, LLC152.88K0.13%+186.2%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of CRDL

Cardiol Therapeutics top fund holders
FundShares% Held
SPDR INDEX SHARES Fd.S-State Street SPDR S&P Intl Small Cap ETF100.00K0.08%
Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund18.47K0.02%

Frequently asked questions

Who is the largest shareholder of Cardiol Therapeutics?

MMCAP International, Inc. SPC is the largest institutional shareholder of CRDL, owning 12.83% of shares outstanding (15.60M shares) as of its latest 13F filing.

What percentage of Cardiol Therapeutics is owned by institutions?

Institutions own about 26.9% of CRDL shares and 27.5% of the public float.

How much of Cardiol Therapeutics do insiders own?

Insiders, such as officers and directors, own about 2.22% of CRDL shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related